Table 7.
Baseline characteristics of patients in CT with CIK, TACE with CIK and TACE groups
| Characteristics | TACE With CIK | CT with CIK | TACE without CIK | P-value |
|---|---|---|---|---|
| Age (yrs) | 54.38+11.40 | 54+12.13 | 57.92+12.12 | 0.142 |
| Gender | 0.663 | |||
| Male | 48 (92.3%) | 54 (93.1%) | 57 (96.6%) | |
| Female | 4 (7.7%) | 4 (6.9%) | 2 (3.4%) | |
| Tumor size | 75.83+35.95 | 72.21+34.72 | 75.26+28.67 | 0.894 |
| Vascular invasion | 0.124 | |||
| Positive | 17 (32.7%) | 19 (32.8%) | 27 (45.8%) | |
| Negative | 35 (67.3%) | 39 (67.2%) | 32 (54.2%) | |
| AFP Levels | 400.78+551.94 | 1248.35+4790.08 | 561.41+560.82 | 0.246 |
| HBV infection | 0.700 | |||
| Positive | 47 (90.4%) | 55 (94.8%) | 56 (94.9%) | |
| Negative | 4 (7.7%) | 2 (5.2%) | 3 (5.1%) | |
| Liver cirrhosis | 0.324 | |||
| Positive | 44 (84.6%) | 46 (79.3%) | 43 (72.9%) | |
| Negative | 8 (15.4%) | 12 (20.7%) | 16 (27.1%) | |
| Tumor number | 0.015 | |||
| > 1 | 19 (36.5%) | 10 (17.2%) | 24 (40.7%) | |
| 1 | 33 (63.5%) | 48 (82.8%) | 35 (59.3%) | |
| Tumor stage | 0.763 | |||
| I+II | 17 (32.7%) | 19 (32.8%) | 16 (27.1%) | |
| III+IV | 35 (67.3%) | 39 (67.2%) | 43 (72.9%) | |
| Child-Pugh Classification Grade | 0.021* | |||
| A | 28 (53.8%) | 35 (60.3%) | 46 (78%) | |
| B and C | 24 (46.2%) | 23 (39.7%) | 13 (22%) | |
| ALT | 46.88+ 30.53 | 60.24+43.41 | 49.98+28.29 | 0.255 |
| ALB | 37.21+4.64 | 38.24+4.08 | 38.49+5.36 | 0.336 |
| TBIL | 25.10+18.88 | 20.97+17.96 | 18.4+9.69 | 0.090** |
| PT | 14.85+2.47 | 14.04+2.01 | 13.94+1.24 | 0.033*** |
*
(TACE with CIK VS. TACE without CIK, P = 0.008; CT with CIK VS. TACE without CIK P = 0.045);
**
(TACE without CIK VS. CT with CIK, P = 0.029);
***
(TACE with CIK VS. TACE without CIK, P = 0.004; TACE with CIK VS. CT with CIK, P = 0.034).